Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atorvastatin Compared With Simvastatin In The Prevention of CHD Morbidity And Mortality In Patients With CHD

NCT00159835 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00159835
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00159835 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atorvastatin Compared With Simvastatin In The Prevention of CHD Morbidity And Mortality In Patients With CHD
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Completed
Start date
February 28, 1999
Completion date
March 31, 2005
Enrollment
8,600
Sites
194

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases